REGENXBIO Says FDA Path Opens for Hunter Syndrome Gene Therapy, Plans Quick FDA Resubmission for One-Time Rare Disease Treatment

뉴스 본문을 불러오고 있어요.

REGENXBIO Says FDA Path Opens for Hunter Syndrome Gene Therapy, Plans Quick FDA Resubmission for One-Time Rare Disease Treatment | 웨이프 WAPE

기사 요약